purine/kansè

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 122 rezilta yo

Purine derivatives as CD73 inhibitors for the treatment of cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

TECHNICAL FIELD OF THE INVENTION The present invention is directed to novel inhibitors of CD73, processes for their preparation, pharmaceutical compositions containing these inhibitors, and their use in the treatment of cancer and other diseases mediated by CD73. BACKGROUND OF THE INVENTION CD73 or

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention is directed to compounds, methods and compositions for treating or preventing viral infections using nucleotide analogs. More specifically, the invention describes 6-substituted-2-amino purine nucleoside monophosphate and monophosphonate prodrugs and

Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Tumor treatment with arabinofuranosyl purine derivatives

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The present invention relates to the antitumour and immunomodulatory activities of certain arabinofuranosyl purine derivatives. It has been reported (Blood, 61, (1983), 660; J. Clin. Invest., 74, (1984), 951 and Cancer Research, 45, (1985), 1008) that arabinofuranosyl guanine (ara G) selectively

Purine compounds and method for the treatment of cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE DISCLOSURE The present disclosure relates to novel compounds, pharmaceutical compositions containing same and methods for the treatment of cancer using same. BACKGROUND OF THE DISCLOSURE A broad group of diseases involving unregulated cell growth is known as cancer or as malignant

9-(pyrazol-3-yl)-9H-purine-2-amine and 3-(pyrazol-3-yl) -3H-imidazo[4,5-B] pyridin-5-amine derivatives and their use for the treatment of cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a US National Stage under 35 U.S.C. .sctn.371 of International Application No. PCT/GB2008/050321 (filed May 2, 2008) which claims priority under 35 U.S.C. .sctn.119(e) to U.S. Provisional Application No. 60/916,270 (filed on May 4,

Purine-core inhibitors of HSP90 and their use in treating cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT N/A FIELD OF THE INVENTION The invention relates to novel compounds and their use to treat diseases. BACKGROUND OF THE INVENTION Cancer is prevalent: In the United States, the probability of developing invasive cancer is 38% for females

2-amino-6-anilino-purines and their use as medicaments

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The invention relates to 2-amino-6-anilino-purine derivatives and to processes and novel intermediates for their preparation, pharmaceutical formulations which comprise such derivatives, and the use of these derivatives as medicaments. The invention relates to 2-amino-6-anilino-purine derivatives of

1,2,3-Triazolyl purine derivatives

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION The Cu-catalyzed version of the classic Huisgen azide-alkyne cycloaddition is a highly atom-economical reaction, often requiring mild conditions. Both factors render Cu-catalyzed azide-alkyne cycloaddition (CuAAC) highly attractive for the modification of complex and

Purine derivatives

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION This invention relates to purine derivatives, to processes for their preparation, to compositions containing them and to their use. More particularly, the present invention relates to the use of purine derivatives in the treatment of a variety of viral infections and

Pyrimidine substituted purine derivatives

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD The present invention relates to purine compounds that may be useful as kinase inhibitors. More particularly, the present invention relates to 2-(morpholin-4-yl), 6-(pyrimidin-5-yl) substituted purine derivatives, methods for their preparation, pharmaceutical compositions containing these

Pyrimidine substituted purine derivatives

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

CROSS REFERENCE TO RELATED APPLICATIONS This application is a National Phase filing under 35 U.S.C. .sctn.371 of PCT/SG2008/000379 filed Oct. 3, 2008, which claims priority to Provisional Patent Application No. 60/977,720, filed in the United States on Oct. 5, 2007, and Provisional Patent

Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to mutant purine nucleoside phosphorylase enzymes having different activity than the non-mutant purine nucleoside phosphorylase enzyme, and to nucleoside substrates for these mutant enzymes. In particular the invention

Cyclopropanecarboxylate esters of purine analogues

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

FIELD OF THE INVENTION The present invention relates generally to ganciclovir cyclopropanecarboxylate ester derivatives and intermediates, preparation and the use thereof. BACKGROUND OF THE INVENTION U.S. Pat. No. 4,162,328 discloses cyclopropane carboxylic acid esters for use as pesticides. U.S.

Substituted purine compounds

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND OF THE INVENTION Disease-associated chromatin-modifying enzymes (e.g., DOT1L) play a role in diseases and disorders such as proliferative disorders, metabolic disorders and blood disorders. Thus, there is a need for the development of small molecules that are capable of modulating the

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye